Healthcare Realty Trust Incorporated (HR)
NYSE: HR · Real-Time Price · USD
14.50
-0.04 (-0.28%)
At close: May 30, 2025, 4:00 PM
14.75
+0.25 (1.72%)
After-hours: May 30, 2025, 7:49 PM EDT
Healthcare Realty Trust Stock Forecast
Stock Price Forecast
According to 5 professional analysts, the 12-month price target for Healthcare Realty Trust stock ranges from a low of $16 to a high of $19. The average analyst price target of $17 forecasts a 17.24% increase in the stock price over the next year.
Price Target: $17.00 (+17.24%)
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for Healthcare Realty Trust stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 5 | 4 | 2 | 2 | 2 | 3 |
| Sell | 1 | 2 | 2 | 3 | 3 | 2 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 6 | 4 | 5 | 5 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wedbush | Wedbush | Hold Maintains $18 → $16 | Hold | Maintains | $18 → $16 | +10.34% | May 5, 2025 |
| Wells Fargo | Wells Fargo | Sell Maintains $17 → $16 | Sell | Maintains | $17 → $16 | +10.34% | Mar 10, 2025 |
| Scotiabank | Scotiabank | Hold Maintains $18 → $17 | Hold | Maintains | $18 → $17 | +17.24% | Feb 25, 2025 |
| Wedbush | Wedbush | Hold → Sell Downgrades $18 → $16 | Hold → Sell | Downgrades | $18 → $16 | +10.34% | Jan 2, 2025 |
| JP Morgan | JP Morgan | Buy → Hold Downgrades $19 | Buy → Hold | Downgrades | $19 | +31.03% | Dec 20, 2024 |
Financial Forecast
Revenue This Year
1.22B
from 1.27B
Decreased by -3.48%
Revenue Next Year
1.26B
from 1.22B
Increased by 2.53%
EPS This Year
-0.34
from -1.81
EPS Next Year
-0.34
from -0.34
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | 1.3B | 1.3B | 1.3B | |
| Avg | 1.2B | 1.3B | 1.3B | |
| Low | 1.1B | 1.1B | 1.2B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | 1.2% | 8.1% | 5.0% | |
| Avg | -3.5% | 2.5% | -0.2% | |
| Low | -11.2% | -6.5% | -7.3% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -0.16 | -0.20 | -0.34 |
| Avg | -0.34 | -0.34 | -0.37 |
| Low | -0.47 | -0.42 | -0.39 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.